Entasis Therapeutics Holdings Inc. Contracts & Agreements

Agreement and Plan of Merger, dated as of May 23, 2022, among the Company, Parent and Merger Sub (Filed With SEC on May 23, 2022)

Amendment No. 1 to Investor Rights Agreement, dated as of May 23, 2022, by and between the Company and Parent (Filed With SEC on May 23, 2022)

Second Amended Non-Employee Director Compensation Policy, as amended January 1, 2022 (Filed With SEC on March 3, 2022)

Amendment to Incentive Stock Option Agreement for employees under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)

Amendment to Incentive Stock Option Agreement for senior management under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)

Amendment to Nonqualified Stock Option Agreement for employees under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)

Amendment to Nonqualified Stock Option Agreement for senior management under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)

Amendment to Stock Option Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Amendment to Restricted Stock Unit Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Amended Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Amended Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Form of Retention Bonus Award Memo (Filed With SEC on March 3, 2022)

Convertible Promissory Note, dated February 18, 2022 (Filed With SEC on February 18, 2022)

Form of Warrant Certificate (Filed With SEC on February 18, 2022)

Securities Purchase Agreement, dated February 17, 2022, by and between the Company and Innoviva (Filed With SEC on February 18, 2022)

Registration Rights Agreement, dated February 18, 2022 by and between the Company and Innoviva (Filed With SEC on February 18, 2022)

Sales Agreement, dated August 27, 2021, between Entasis Therapeutics Holdings Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 27, 2021)

Form of Warrant Certificate (Filed With SEC on May 3, 2021)

Securities Purchase Agreement, dated May 3, 2021, by and between the Company and Innoviva (Filed With SEC on May 3, 2021)

Form of Registration Rights Agreement (Filed With SEC on May 3, 2021)

Form of Restricted Stock Unit Grant Notice (Time-Based) (Filed With SEC on November 6, 2020)

Form of Restricted Stock Unit Grant Notice (Performance-Based) (Filed With SEC on November 6, 2020)

Form of Restricted Stock Unit Grant Agreement (Filed With SEC on November 6, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)

Securities Purchase Agreement, dated August 27, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)

Registration Rights Agreement, dated September 1, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)

Amended Non-employee Director Compensation Policy, as amended December 6, 2019 (Filed With SEC on August 6, 2020)

Special Bonus Award Memorandum, dated May 15, 2020 (Filed With SEC on August 6, 2020)

First Amendment to 2018 Equity Incentive Plan (Filed With SEC on August 6, 2020)

Form of Executive Officer Employment Agreement (Filed With SEC on May 7, 2020)

Employment Agreement between the Company and Eric Kimble, effective September 6, 2019 (Filed With SEC on May 7, 2020)

Non-employee Director Compensation Policy, as amended June 19, 2019 (Filed With SEC on May 7, 2020)

Registration Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)

Investor Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)

Form of Warrant Certificate (Filed With SEC on April 13, 2020)

Form of Registration Rights Agreement (Filed With SEC on April 13, 2020)

Securities Purchase Agreement, dated April 12, 2020, by and between the Company and Innoviva (Filed With SEC on April 13, 2020)

Form of Voting Agreement (Filed With SEC on April 13, 2020)

Form of Investor Rights Agreement (Filed With SEC on April 13, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2020)

Non-Employee Director Compensation Policy (Filed With SEC on March 11, 2020)

Registration Rights Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)

Common Stock Purchase Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)

Employment Agreement between the Company and Ruben Tommasi, effective September 25, 2018 (Filed With SEC on March 29, 2019)

Novation of Contract, dated January 11, 2019, by and between the Global Antibiotic Research and Development Partnership and the Company (Filed With SEC on March 29, 2019)

2018 Equity Incentive Plan (Filed With SEC on November 14, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on November 14, 2018)

Form of Underwriting Agreement (Filed With SEC on September 18, 2018)

Registration Rights Agreement, dated as of September 14, 2018 (Filed With SEC on September 18, 2018)

Employment Agreement with Manoussos Perros (Filed With SEC on September 18, 2018)

Employment Agreement with Michael Gutch (Filed With SEC on September 18, 2018)

Employment Agreement with Robin Isaacs (Filed With SEC on September 18, 2018)

Form of Indemnification Agreement by and between the Registrant and each of its directors and officers (Filed With SEC on September 18, 2018)